Drug development dermatology
HBM contact: Dr Ivo Staijen, Dr Alexander Asam
Company status: public
Arcutis Biotherapeutics is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology.